Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fust Matthew K
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   351,844    

Indirect Shares

   0      
Direct Value   $8,065,381    

Indirect Value

   $0      
Total Shares   351,844      
Total Value   $8,065,381      


Jazz Pharmaceuticals Inc $6,441,248 Ultragenyx Pharmaceutical Inc $657,406 Macrogenics Inc $7,280 Atara Biotherapeutics, Inc. $178,710 Crinetics Pharmaceuticals, Inc. $780,736 Jazz Pharmaceuticals Inc $6,441,248 Ultragenyx Pharmaceutical Inc $657,406 Macrogenics Inc $7,280 Atara Biotherapeutics, Inc. $178,710 Crinetics Pharmaceuticals, Inc. $780,736
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -13.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Jazz Pharmaceuticals Inc JAZZ EVP, Chief Financial O... 2008-11-28 58,948 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Financial ... 2013-10-01 0 2009-01-05 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE 2024-03-07 14,860 2014-01-30 0    Premium*  
            Macrogenics Inc MGNX Director 2019-02-06 500 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 2024-03-31 259,000 2015-05-15 0    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX Director 2024-03-20 18,536 2019-12-16 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ATRA Atara Biotherapeutics, In...   •       •      –    2024-03-31 4 A $0.00 $0 D/D 150,000 259,000 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2024-03-20 4 AS $43.57 $2,648,150 D/D (60,000) 18,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2024-03-20 4 OE $18.29 $1,254,975 D/D 60,000 36,036 0 -
RARE Ultragenyx Pharmaceutical...   –       •      –    2024-03-07 4 S $50.85 $620,443 D/D (12,195) 14,860 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2023-06-16 4 A $0.00 $0 D/D 6,000 18,536 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2023-06-07 4 A $0.00 $0 D/D 3,860 30,355 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2023-06-07 4 D $51.82 $171,006 D/D (3,300) 27,055 0 -
ATRA Atara Biotherapeutics, In...   •       •      –    2023-05-31 4 A $0.00 $0 D/D 57,000 109,000 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2022-07-13 4 AS $20.96 $119,455 D/D (5,700) 12,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2022-07-13 4 OE $1.45 $8,265 D/D 5,700 18,236 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2022-06-24 4 A $0.00 $0 D/D 3,300 26,495 0 -
ATRA Atara Biotherapeutics, In...   •       •      –    2022-06-23 4 A $0.00 $0 D/D 20,500 52,000 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2022-03-04 4 OE $40.37 $302,775 D/D 7,500 23,195 0 -
ATRA Atara Biotherapeutics, In... Director   –       •      –    2021-11-04 4 AS $19.50 $260,403 D/D (13,354) 31,500 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-11-01 4 AS $25.50 $228,327 D/D (8,954) 12,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-11-01 4 OE $1.91 $17,102 D/D 8,954 21,490 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-09-08 4 AS $25.50 $154,173 D/D (6,046) 12,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-09-08 4 OE $1.91 $11,548 D/D 6,046 18,582 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-07-26 4 AS $19.59 $97,950 D/D (5,000) 12,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-07-26 4 OE $1.91 $9,550 D/D 5,000 17,536 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-07-12 4 AS $20.71 $103,550 D/D (5,000) 12,536 0 %
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2021-07-12 4 OE $1.91 $9,550 D/D 5,000 17,536 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2021-06-24 4 A $0.00 $0 D/D 2,145 15,695 0 -
ATRA Atara Biotherapeutics, In...   •       •      –    2021-06-08 4 A $0.00 $0 D/D 11,000 44,854 0 -
RARE Ultragenyx Pharmaceutical... Director   –       •      –    2020-07-06 4 AS $90.00 $556,290 D/D (6,181) 13,550 0 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us